Academic Journal
Προβολή σε EDS

Generalized Pustular Psoriasis with Cushing’s Syndrome: A Case of Effective Spesolimab Treatment

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Generalized Pustular Psoriasis with Cushing’s Syndrome: A Case of Effective Spesolimab Treatment
Συγγραφείς: Peng G, Zhang Y, Zhang S, Li Y, Luo L, Luo J, Nie X, Zhang H, Liao C
Πηγή: Biologics: Targets & Therapy, Vol 19, Iss Issue 1, Pp 321-329 (2025)
Στοιχεία εκδότη: Dove Medical Press, 2025.
Έτος έκδοσης: 2025
Συλλογή: LCC:Medicine (General)
Θεματικοί όροι: Generalized Pustular Psoriasis, Spesolimab, Biologic Agents, Case Report, Medicine (General), R5-920
Περιγραφή: Guoyao Peng,* Yun Zhang,* Shuang Zhang,* You Li, Liping Luo, Jiaxin Luo, Xinyi Nie, Hongwei Zhang, Chengcheng Liao Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan Province, People’s Republic of China*These authors contributed equally to this workCorrespondence: Chengcheng Liao, Yunnan University of Traditional Chinese Medicine, No. 1076, Yuhua Road, Chenggong District, Kunming, Yunnan Province, People’s Republic of China, Email liaochengcheng2024@163.comAbstract: Generalized pustular psoriasis (GPP) is a rare neutrophilic skin disease characterized by persistent symptoms and sudden onset of painful, sterile pustules. These pustules may be accompanied by systemic inflammation and can be life-threatening in severe cases. Presently, there is an absence of standardized guidelines for treatment, and the majority of conventional treatments employed by clinicians are predicated on the utilization of glucocorticosteroids, immunosuppressants, and retinoids to attain anti-inflammatory and immune-suppressing effects. However, the therapeutic effect is often unsatisfactory and patients are prone to side effects. The IL-36 receptor monoclonal antibody, Spesolimab, signifies a novel therapeutic modality that has received approval from both the National Drug Administration (NMPA) of China and the US Food and Drug Administration (FDA) for the management of acute exacerbations of GPP. We report a case of a 40-year-old male patient diagnosed with GPP who had no significant improvement in symptoms and development of Cushing’s syndrome after up to six months of treatment with glucocorticoids, immunosuppressants, and retinoids. The patient was treated with Spesolimab, a monoclonal antibody, resulting in a substantial improvement in symptoms. This development offers novel treatment options and provides a reference for clinical medication for patients with this particular type of GPP.Keywords: generalized pustular psoriasis, spesolimab, biologic agents, case report
Τύπος εγγράφου: article
Περιγραφή αρχείου: electronic resource
Γλώσσα: English
ISSN: 1177-5491
Relation: https://www.dovepress.com/generalized-pustular-psoriasis-with-cushings-syndrome-a-case-of-effect-peer-reviewed-fulltext-article-BTT; https://doaj.org/toc/1177-5491
Σύνδεσμος πρόσβασης: https://doaj.org/article/e0b2d6f8f8294c0eaaac25fe31ae3e18
Αριθμός Καταχώρησης: edsdoj.0b2d6f8f8294c0eaaac25fe31ae3e18
Βάση Δεδομένων: Directory of Open Access Journals
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://doaj.org/article/e0b2d6f8f8294c0eaaac25fe31ae3e18
    Name: EDS - DOAJ (ns324271)
    Category: fullText
    Text: View record in DOAJ
  – Url: https://resolver.ebsco.com/c/fiv2js/result?sid=EBSCO:edsdoj&genre=article&issn=11775491&ISBN=&volume=19&issue=Issue%201&date=20250501&spage=321&pages=321-329&title=Biologics: Targets & Therapy&atitle=Generalized%20Pustular%20Psoriasis%20with%20Cushing%E2%80%99s%20Syndrome%3A%20A%20Case%20of%20Effective%20Spesolimab%20Treatment&aulast=Peng%20G&id=DOI:
    Name: Full Text Finder (for New FTF UI) (ns324271)
    Category: fullText
    Text: Full Text Finder
    MouseOverText: Full Text Finder
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.0b2d6f8f8294c0eaaac25fe31ae3e18
RelevancyScore: 1049
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 1048.53210449219
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Generalized Pustular Psoriasis with Cushing’s Syndrome: A Case of Effective Spesolimab Treatment
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Peng+G%22">Peng G</searchLink><br /><searchLink fieldCode="AR" term="%22Zhang+Y%22">Zhang Y</searchLink><br /><searchLink fieldCode="AR" term="%22Zhang+S%22">Zhang S</searchLink><br /><searchLink fieldCode="AR" term="%22Li+Y%22">Li Y</searchLink><br /><searchLink fieldCode="AR" term="%22Luo+L%22">Luo L</searchLink><br /><searchLink fieldCode="AR" term="%22Luo+J%22">Luo J</searchLink><br /><searchLink fieldCode="AR" term="%22Nie+X%22">Nie X</searchLink><br /><searchLink fieldCode="AR" term="%22Zhang+H%22">Zhang H</searchLink><br /><searchLink fieldCode="AR" term="%22Liao+C%22">Liao C</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Biologics: Targets & Therapy, Vol 19, Iss Issue 1, Pp 321-329 (2025)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Dove Medical Press, 2025.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2025
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Medicine (General)
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Generalized+Pustular+Psoriasis%22">Generalized Pustular Psoriasis</searchLink><br /><searchLink fieldCode="DE" term="%22Spesolimab%22">Spesolimab</searchLink><br /><searchLink fieldCode="DE" term="%22Biologic+Agents%22">Biologic Agents</searchLink><br /><searchLink fieldCode="DE" term="%22Case+Report%22">Case Report</searchLink><br /><searchLink fieldCode="DE" term="%22Medicine+%28General%29%22">Medicine (General)</searchLink><br /><searchLink fieldCode="DE" term="%22R5-920%22">R5-920</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Guoyao Peng,* Yun Zhang,* Shuang Zhang,* You Li, Liping Luo, Jiaxin Luo, Xinyi Nie, Hongwei Zhang, Chengcheng Liao Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan Province, People’s Republic of China*These authors contributed equally to this workCorrespondence: Chengcheng Liao, Yunnan University of Traditional Chinese Medicine, No. 1076, Yuhua Road, Chenggong District, Kunming, Yunnan Province, People’s Republic of China, Email liaochengcheng2024@163.comAbstract: Generalized pustular psoriasis (GPP) is a rare neutrophilic skin disease characterized by persistent symptoms and sudden onset of painful, sterile pustules. These pustules may be accompanied by systemic inflammation and can be life-threatening in severe cases. Presently, there is an absence of standardized guidelines for treatment, and the majority of conventional treatments employed by clinicians are predicated on the utilization of glucocorticosteroids, immunosuppressants, and retinoids to attain anti-inflammatory and immune-suppressing effects. However, the therapeutic effect is often unsatisfactory and patients are prone to side effects. The IL-36 receptor monoclonal antibody, Spesolimab, signifies a novel therapeutic modality that has received approval from both the National Drug Administration (NMPA) of China and the US Food and Drug Administration (FDA) for the management of acute exacerbations of GPP. We report a case of a 40-year-old male patient diagnosed with GPP who had no significant improvement in symptoms and development of Cushing’s syndrome after up to six months of treatment with glucocorticoids, immunosuppressants, and retinoids. The patient was treated with Spesolimab, a monoclonal antibody, resulting in a substantial improvement in symptoms. This development offers novel treatment options and provides a reference for clinical medication for patients with this particular type of GPP.Keywords: generalized pustular psoriasis, spesolimab, biologic agents, case report
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 1177-5491
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: https://www.dovepress.com/generalized-pustular-psoriasis-with-cushings-syndrome-a-case-of-effect-peer-reviewed-fulltext-article-BTT; https://doaj.org/toc/1177-5491
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/e0b2d6f8f8294c0eaaac25fe31ae3e18" linkWindow="_blank">https://doaj.org/article/e0b2d6f8f8294c0eaaac25fe31ae3e18</link>
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.0b2d6f8f8294c0eaaac25fe31ae3e18
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsdoj&AN=edsdoj.0b2d6f8f8294c0eaaac25fe31ae3e18
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 321
    Subjects:
      – SubjectFull: Generalized Pustular Psoriasis
        Type: general
      – SubjectFull: Spesolimab
        Type: general
      – SubjectFull: Biologic Agents
        Type: general
      – SubjectFull: Case Report
        Type: general
      – SubjectFull: Medicine (General)
        Type: general
      – SubjectFull: R5-920
        Type: general
    Titles:
      – TitleFull: Generalized Pustular Psoriasis with Cushing’s Syndrome: A Case of Effective Spesolimab Treatment
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Peng G
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Zhang S
      – PersonEntity:
          Name:
            NameFull: Li Y
      – PersonEntity:
          Name:
            NameFull: Luo L
      – PersonEntity:
          Name:
            NameFull: Luo J
      – PersonEntity:
          Name:
            NameFull: Nie X
      – PersonEntity:
          Name:
            NameFull: Zhang H
      – PersonEntity:
          Name:
            NameFull: Liao C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 11775491
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: Issue 1
          Titles:
            – TitleFull: Biologics: Targets & Therapy
              Type: main
ResultId 1